Keith GravesPresident and Primary Instructor
areas of expertise
- Drug Enforcement
- Drug Trends
- Drug Abuse Recognition
- Narcotic Unit Supervision
- SWAT Team Operations
- Sniper Team Operations
education
- BA, Business Management, St. Mary’s College of California
- MA, Criminal Justice, American Military University
- Drug Recognition Expert Instructor (certification #3292)
Keith is a retired Police Sergeant and worked in the San Francisco Bay Area for 29 years. Keith was named as California’s Narcotics Officer of the Year and is a prior winner of MADD’s California Hero Award. He has years of experience as a Narcotics Detective and a Narcotics Unit Supervisor and is a Drug Recognition Expert Instructor (IACP #3292). Keith teaches both the DRE course and the Drug Abuse Recognition Course. He has developed several drug courses for the California Narcotics Officers Association, California POST and California Colleges.
in the news
-
The Illicit Use of Vyvanse: A Guide For Law Enforcement
What is Vyvanse? Vyvanse, also known by its generic name lisdexamfetamine, is a prescription-only stimulant used to treat ADHD as well as binge eating disorder. Chemically, it functions similarly to Adderall. However, in recent years, Vyvanse has become increasingly popular due to the Adderall shortage. Vyvanse Reddit Discussion The illicit use of Vyvanse is primarily
March 7, 2023 -
Motorcycle Gangs and Afghan Methamphetamine: A Growing Threat to Australia
The Australian Federal Police (AFP) has launched an investigation targeting outlaw motorcycle gangs (OMGs) involved in a conspiracy to import methamphetamine from Afghanistan to Australia, with large quantities of the illicit drug destined for NSW. More than 250kg of Afghan-produced methamphetamine worth $225 million have been prevented from entering Australia since 2021, with the majority
March 3, 2023 -
BC’s Drug Decriminalization: A Step in the Wrong Direction
The recent move by the government of British Columbia to decriminalize heroin, fentanyl, cocaine, and other hard drugs has caused widespread concern among citizens and healthcare professionals. Rather than reducing harm, as proponents claim, this decision will only lead to an increase in drug use and the associated harms to individuals, communities, and society as
February 7, 2023